purchase customization

Leave This Empty:

choose chapter to purchase

table of content

1 Study Coverage
1.1 Prostate Cancer Revenue in Prostate Cancer Business (2017-2022) & (US$ Million) Introduction
1.2 Global Prostate Cancer Outlook 2017 VS 2022 VS 2028
1.2.1 Global Prostate Cancer Market Size for the Year 2017-2028
1.2.2 Global Prostate Cancer Market Size for the Year 2017-2028
1.3 Prostate Cancer Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Prostate Cancer in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Prostate Cancer Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Prostate Cancer Market Dynamics
1.4.1 Prostate Cancer Industry Trends
1.4.2 Prostate Cancer Market Drivers
1.4.3 Prostate Cancer Market Challenges
1.4.4 Prostate Cancer Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Prostate Cancer by Type
2.1 Prostate Cancer Market Segment by Type
2.1.1 Chemotherapy
2.1.2 Hormonal Therapy
2.1.3 Targeted Therapy
2.1.4 Immunotherapy
2.2 Global Prostate Cancer Market Size by Type (2017, 2022 & 2028)
2.3 Global Prostate Cancer Market Size by Type (2017-2028)
2.4 United States Prostate Cancer Market Size by Type (2017, 2022 & 2028)
2.5 United States Prostate Cancer Market Size by Type (2017-2028)
3 Prostate Cancer by Application
3.1 Prostate Cancer Market Segment by Application
3.1.1 Age Below 55
3.1.2 Age 55-75
3.1.3 Age Above 75
3.2 Global Prostate Cancer Market Size by Application (2017, 2022 & 2028)
3.3 Global Prostate Cancer Market Size by Application (2017-2028)
3.4 United States Prostate Cancer Market Size by Application (2017, 2022 & 2028)
3.5 United States Prostate Cancer Market Size by Application (2017-2028)
4 Global Prostate Cancer Competitor Landscape by Company
4.1 Global Prostate Cancer Market Size by Company
4.1.1 Top Global Prostate Cancer Companies Ranked by Revenue (2021)
4.1.2 Global Prostate Cancer Revenue by Player (2017-2022)
4.2 Global Prostate Cancer Concentration Ratio (CR)
4.2.1 Prostate Cancer Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Prostate Cancer in 2021
4.2.3 Global Prostate Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Prostate Cancer Headquarters, Revenue in Prostate Cancer Business (2017-2022) & (US$ Million) Type
4.3.1 Global Prostate Cancer Headquarters and Area Served
4.3.2 Global Prostate Cancer Companies Revenue in Prostate Cancer Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Prostate Cancer Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Prostate Cancer Market Size by Company
4.5.1 Top Prostate Cancer Players in United States, Ranked by Revenue (2021)
4.5.2 United States Prostate Cancer Revenue by Players (2020, 2021 & 2022)
5 Global Prostate Cancer Market Size by Region
5.1 Global Prostate Cancer Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Prostate Cancer Market Size by Region (2017-2028)
5.2.1 Global Prostate Cancer Market Size by Region: 2017-2022
5.2.2 Global Prostate Cancer Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Prostate Cancer Market Size YoY Growth 2017-2028
6.1.2 North America Prostate Cancer Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Prostate Cancer Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Prostate Cancer Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Prostate Cancer Market Size YoY Growth 2017-2028
6.3.2 Europe Prostate Cancer Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Prostate Cancer Market Size YoY Growth 2017-2028
6.4.2 Latin America Prostate Cancer Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Prostate Cancer Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Prostate Cancer Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Astellas, Inc.
7.1.1 Astellas, Inc. Company Details
7.1.2 Astellas, Inc. Business Overview
7.1.3 Astellas, Inc. Prostate Cancer Introduction
7.1.4 Astellas, Inc. Revenue in Prostate Cancer Business (2017-2022)
7.1.5 Astellas, Inc. Recent Development
7.2 AstraZeneca plc
7.2.1 AstraZeneca plc Company Details
7.2.2 AstraZeneca plc Business Overview
7.2.3 AstraZeneca plc Prostate Cancer Introduction
7.2.4 AstraZeneca plc Revenue in Prostate Cancer Business (2017-2022)
7.2.5 AstraZeneca plc Recent Development
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Details
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Prostate Cancer Introduction
7.3.4 Johnson & Johnson Revenue in Prostate Cancer Business (2017-2022)
7.3.5 Johnson & Johnson Recent Development
7.4 Sanofi S.A
7.4.1 Sanofi S.A Company Details
7.4.2 Sanofi S.A Business Overview
7.4.3 Sanofi S.A Prostate Cancer Introduction
7.4.4 Sanofi S.A Revenue in Prostate Cancer Business (2017-2022)
7.4.5 Sanofi S.A Recent Development
7.5 Bristol Myers Squibb (BMS)
7.5.1 Bristol Myers Squibb (BMS) Company Details
7.5.2 Bristol Myers Squibb (BMS) Business Overview
7.5.3 Bristol Myers Squibb (BMS) Prostate Cancer Introduction
7.5.4 Bristol Myers Squibb (BMS) Revenue in Prostate Cancer Business (2017-2022)
7.5.5 Bristol Myers Squibb (BMS) Recent Development
7.6 Bayer AG
7.6.1 Bayer AG Company Details
7.6.2 Bayer AG Business Overview
7.6.3 Bayer AG Prostate Cancer Introduction
7.6.4 Bayer AG Revenue in Prostate Cancer Business (2017-2022)
7.6.5 Bayer AG Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer